Thorpe-Beeston J G, Nicolaides K H, Snijders R J, Butler J, McGregor A M
Harris Birthright Research Centre for Fetal Medicine, King's College School of Medicine and Dentistry, London, United Kingdom.
Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1244-5. doi: 10.1016/0002-9378(91)90692-k.
Thyroid-stimulating hormone was measured in fetal blood samples obtained by cordocentesis before and after blood transfusion in Rh-affected pregnancies at 25 to 37 weeks' gestation. In eight of 26 study subjects thyrotropin-releasing hormone was given to the mothers immediately after the pretransfusion samples were obtained. In this group the fetal thyroid-stimulating hormone concentrations in the posttransfusion samples were significantly higher than those before the transfusion.
在妊娠25至37周的受Rh影响的妊娠中，通过脐血穿刺术在输血前后获取胎儿血样，检测促甲状腺激素。在26名研究对象中的8名中，在获取输血前样本后立即给母亲注射促甲状腺激素释放激素。在该组中，输血后样本中的胎儿促甲状腺激素浓度显著高于输血前。
